Credit Assessment: PHARMAWORK LIMITED (04042971)

1. Credit Opinion: DECLINE

This application warrants a DECLINE for any meaningful commercial credit facility. The company exhibits chronic financial stagnation over an extended period, with a balance sheet that has been essentially frozen for six consecutive years. Net assets have slowly eroded from £6,845 (2017) to £6,158 (2025), representing a 10% decline. The entity possesses negligible asset coverage, zero employees, and no evidence of revenue-generating capacity from the filed information. The balance sheet is wholly inadequate to support debt servicing obligations, and there is no visible financial trajectory suggesting improvement.

2. Financial Strength

Balance Sheet Summary (as at 31 July 2025):

Key Observations:

• Stagnant Balance Sheet: Total assets have remained at ~£17,665 for six consecutive years (2020-2025), indicating no business activity generating asset growth. This is highly unusual and suggests the company may be dormant in all but name.

• Minimal Net Worth: Net assets of £6,158 provide virtually no buffer for creditor protection. This figure has actually declined from £6,845 in 2017, representing cumulative losses or withdrawals eroding equity.

• Structural Change in 2017: A significant contraction occurred between 2017-2018, with total assets dropping from £41,851 to £17,791 and liabilities reducing from £35,006 to £11,000. This suggests a major business restructuring, asset disposal, or change in operational model.

• Liability Composition: Current liabilities of £11,000 (likely director-related or trade creditors) have remained static for six years, which is a red flag for financial activity.

• Accruals: £506 in accruals and deferred income, also unchanged year-on-year.

• Shareholder Equity Erosion: The P&L reserve shows accumulated losses or withdrawals exceeding share capital, with shareholders' funds at £6,158 against share capital of £10,001.

3. Cash Flow Assessment

Liquidity Position:

Assessment:

• Current Ratio: At 1.61x, the current ratio appears adequate on the surface, but this is misleading. The current assets figure likely comprises minimal cash and perhaps a debtor or two, given the company's micro-entity status and zero employees.

• No Revenue Visibility: As a micro-entity filer, the company is not required to file a profit & loss account. We have no visibility on turnover, gross margin, or operating profit. The static balance sheet strongly suggests negligible trading activity.

• Working Capital Concern: Net current assets of £6,664 are insufficient to support any meaningful commercial obligation. A single unexpected liability could render the company insolvent.

• Cash Generation: The slow erosion of net assets (£6,845 → £6,158 over 8 years) indicates the company is not generating positive cash flow, or any profits are being extracted entirely.

• Debt Service Capacity: With no visible income stream and minimal assets, the company has no demonstrated capacity to service debt repayments from operations.

4. Monitoring Points

If any credit exposure were considered (which is not recommended), the following would require ongoing monitoring:

Specific Monitoring Requirements:

1. Trading Status Verification: Confirm whether the company is actively trading or effectively dormant. The static balance sheet strongly suggests minimal or no trading activity.

2. Revenue Confirmation: If any facility were contemplated, full management accounts showing turnover, gross margin, and net profit would be essential. Micro-entity accounts are insufficient for credit assessment.

3. Liability Identification: The nature of the £11,000 current liabilities must be clarified—whether these are trade creditors, director loans, or other obligations.

4. Director's Personal Position: As a single-director, zero-employee company, the financial position of Mr. MacLennan would be critical for any personal guarantee assessment.

5. Business Purpose: Clarification needed on why a management consultancy has zero employees and a static balance sheet—this may indicate the company is being used as a personal service vehicle or is no longer actively trading.

Additional Risk Factors

• Single Director Dependency: Mr. Derek James MacLennan is the sole director and PSC (owning 25-50% of shares). Key person risk is absolute—any incapacity would immediately threaten the company's existence.

• Micro-Entity Filing Limitations: The company benefits from minimal disclosure requirements, meaning significant information asymmetry exists for creditors. No P&L, no cash flow statement, no detailed notes beyond employee count.

• Industry Mismatch: The SIC code (70229 - Management consultancy) does not align with the balance sheet profile of a consultancy business, which would typically show higher current assets (debtors) and more variable liabilities if actively trading.

• Long-Term Stagnation: A company incorporated in 2000 that has shown zero growth for 6+ years raises fundamental questions about business viability and management ambition.